Edition:
United States

Cardinal Health Inc (CAH)

CAH on New York Consolidated

72.98USD
23 May 2017
Change (% chg)

$-0.11 (-0.15%)
Prev Close
$73.09
Open
$73.10
Day's High
$73.32
Day's Low
$72.83
Volume
355,710
Avg. Vol
2,253,323
52-wk High
$85.52
52-wk Low
$62.70

Select another date:

Wed, May 3 2017

BRIEF-Cardinal Health board approved 3 pct increase in qtrly dividend

* Cardinal Health -board of directors approved a 3 percent increase in company's quarterly dividend from $0.4489 per share to $0.4624 per share Source text for Eikon: Further company coverage:

BRIEF-Cardinal Health says generic pricing definitely getting better

* Ceo says "experiencing pricing deflation in generics, some heightened reimbursement pressures which affect our customers"-conf call

Cardinal Health quarterly profit ahead of estimates

Cardinal Health Inc reported a better-than-expected quarterly profit, helped by strong performance in its medical unit even as the drug distributor continues to face declining generic drug prices.

UPDATE 1-Cardinal Health quarterly profit ahead of estimates

May 1 Cardinal Health Inc reported a better-than-expected quarterly profit, helped by strong performance in its medical unit even as the drug distributor continues to face declining generic drug prices.

BRIEF-Cardinal Health Q3 non-gaap EPS $1.53

* Cardinal health reports third-quarter results for fiscal year 2017

Cardinal Health quarterly revenue rises 3.8 pct

May 1 Cardinal Health Inc reported a 3.8 percent rise in quarterly revenue, helped by strength in its pharmaceutical business even as the drug distributor faces declining generic drug prices.

Deals of the day-Mergers and acquisitions

April 18 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

Cardinal Health's dull forecast drags along rivals' shares

Cardinal Health Inc said on Tuesday it expected full-year adjusted earnings at the lower end of its forecast, underscoring the U.S. drug distribution industry's struggles with declining generic drug prices.

UPDATE 3-Cardinal Health's dull forecast drags along rivals' shares

* Shares fall 12 pct; rivals down 5 pct (Adds analyst comments, shares)

Fitch Revises Cardinal Health's Outlook to Negative Following $6B Deal

(The following statement was released by the rating agency) NEW YORK/BUENOS AIRES, April 18 (Fitch) Fitch Ratings has revised Cardinal Health, Inc.'s (Cardinal, NYSE: CAH) Rating Outlook to Negative from Stable following the announcement that it had agreed to acquire certain assets from Medtronic (Not Rated) for approximately $6 billion. KEY RATING DRIVERS The Negative Outlook reflects Fitch's expectation that Cardinal's leverage will remain elevated for the rating category for an extended perio

Select another date:

More From Around the Web